Sales Growth Across All Segments
Group sales increased by 7% in the first half of the fiscal year, with growth in all three business segments: Consumer Care, Life Sciences, and Industrial Specialties.
Significant Volume Growth
Volumes were up 11%, contributing to an improvement in operating margin from 16.6% to 17.2% year-on-year.
Cost Savings Plan
The company has identified GBP 100 million of annualized cost savings by the end of 2027, up from an initial target of GBP 40 million.
Strong Performance in Europe
Sales in Europe increased by 12%, driven by strong performance in Consumer Care and Life Sciences.
Pharma Sales Growth
Pharma sales grew by 5%, with a focus on improving sales in Consumer Health and veterinary applications.